| The faculty/authors reported the following financial relationships or relationships to products or devices they have with ineligible companies related to the content of this CME activity: | ||
| Name of Author | Role | Reported Financial Relationship |
| Chris E. Adkins | Author | Nothing to disclose |
| Manish K. Aghi | Author | Nothing to disclose |
| Carey K. Anders | Author | Consulting Fee (e.g., Advisory Board): Genentech, Eisai, IPSEN, Seattle Genetics, Astra Zeneca, Novartis, Immunomedics, Elucida, Athenex Contracted Research: PUMA, Lilly, Merck, Seattle Genetics, Nektar, Tesaro, G1-Therapeutics, ZION, Novartis, Pfizer |
| Tasneem A. Arsiwala | Author | Nothing to disclose |
| Sonikpreet Aulakh | Author | Consulting Fee (e.g., Advisory Board): TEMPUS Speakers’ Bureau: TEMPUS |
| Gene H. Barnett | Author | Consulting Fee (e.g., Advisory Board): Monteris Medical |
| Anna S. Berghoff | Author | Consulting Fee (e.g., Advisory Board): Daiichi Sankyo Contracted Research: Daiichi Sankyo, Roche Other (Describe): Travel support from Roche, Amgen and AbbVie |
| Kathryn E. Blethen | Author | Nothing to disclose |
| Adrienne Boire | Author | Other (Describe): Evren Technologies (scientific advisory board - unpaid), Patents (inventor) via Sloan Kettering Institute |
| Priscilla K. Brastianos | Author | Consulting Fee (e.g., Advisory Board): Pfizer, ElevateBio, Dantari, SK Life Sciences, Sintetica, Voyager Therapeutics Contracted Research: Merck, Eli Lilly, BMS, Mirati Honoraria: Pfizer |
| Paul David Brown | Author | Nothing to disclose |
| Leeann B. Burton | Author | Contracted Research: Support to learn about drug development paid to Massachusetts General Hospital by Biogen. |
| Yssabela M. Cabuyao | Author | Nothing to disclose |
| Bryan D. Choi | Author | Nothing to disclose |
| Caroline Chung | Author | Contracted Research: Siemens Healineers, Raysearch Laboratories |
| Michael A. Davies | Author | Consulting Fee (e.g., Advisory Board): Roche/Genentech, Array, Pfizer, Novartis, BMS, GSK, Sanofi-Aventis, Vaccinex, Apexigen, ABM Therapeutics Contracted Research: Roche/Genentech, GSK, Sanofi-Aventis, Array, Pfizer, Oncothyreon |
| Krutika Deshpande | Author | Nothing to disclose |
| Leland E. Earp | Author | Nothing to disclose |
| Mahsa Eskian | Author | Nothing to disclose |
| Peter E. Fecci | Author | Consulting Fee (e.g., Advisory Board): Monteris Medical Contracted Research: Monteris Medical Honoraria: Monteris Medical |
| Ross A. Fladeland | Author | Nothing to disclose |
| Scott R. Floyd | Author | Nothing to disclose |
| Morgan J. Glass | Author | Nothing to disclose |
| Vinai Gondi | Author | Nothing to disclose |
| Matthew M. Grabowski | Author | Nothing to disclose |
| Amanda C. Guidon | Author | Consulting Fee (e.g., Advisory Board): Momenta, Alexion, Ra pharmaceuticals Contracted Research: Momenta Pharma |
| Mustafa Khasraw | Author | Consulting Fee (e.g., Advisory Board): J&J Contracted Research: AbbVie, BMS Honoraria: Jax lab for genomic research |
| Brooke N. Kielkowski | Author | Nothing to disclose |
| Priya Kumthekar | Author | Consulting Fee (e.g., Advisory Board): Janssen, Orbus Therapeutics, Novocure, Celularity, SDP Oncology, Biocept, Affinia, Sintetica, Angiochem Other (Describe): Data Safety Monitoring Committee: Berg Oncology |
| Paul R. Lockman | Author | Nothing to disclose |
| Jacquelyn Meyer | Author | Nothing to disclose |
| Lauritz Miarka | Author | Nothing to disclose |
| Nathaniel J. Myall | Author | Honoraria: Remedy Health Media |
| Brian V. Nahed | Author | Consulting Fee (e.g., Advisory Board): Robeaute |
| Josh Neman | Author | Nothing to disclose |
| Patrick R. Ng | Author | Nothing to disclose |
| Dhruvi M. Panchal | Author | Nothing to disclose |
| Michael W. Parsons | Author | Consulting Fee (e.g., Advisory Board): Agios, Inc, Gamaka Bio |
| Katherine B. Peters | Author | Consulting Fee (e.g., Advisory Board): Vivacitas Oncology, Sapience Contracted Research: Servier, AbbVie, Agios, Biomimetix Honoraria: Eisai-Honoraria for educational event |
| Erqi Pollom | Author | Contracted Research: Genentech |
| Matthias Preusser | Author | Consulting Fee (e.g. Advisory Board): Bayer, Bristol-Myers Squibb, Novartis, Gerson Lehrman Group (GLG), CMC Contrast, GlaxoSmithKline, Mundipharma, Roche, BMJ Journals, MedMedia, Astra Zeneca, AbbVie, Lilly, Medahead, Daiichi Sankyo, Sanofi, Merck Sharp & Dome, Tocagen, Adastra Contracted Research: Boehringer-Ingelheim, Bristol-Myers Squibb, Roche, Daiichi Sankyo, Merck Sharp & Dome, Novocure, GlaxoSmithKline, AbbVie (all payments received by faculty’s institution) Honoraria: Bayer, Bristol-Myers Squibb, Novartis, Gerson Lehrman Group (GLG), CMC Contrast, GlaxoSmithKline, Mundipharma, Roche, BMJ Journals, MedMedia, Astra Zeneca, AbbVie, Lilly, Medahead, Daiichi Sankyo, Sanofi, Merck Sharp & Dome, Tocagen, Adastra |
| Trenton A. Pritt | Author | Nothing to disclose |
| Kerry L. Reynolds | Author | Nothing to disclose |
| Chantal Saberian | Author | Nothing to disclose |
| Sarah Sammons | Author | Consulting Fees (e.g., Advisory Board): Novartis, AstraZeneca, Daiichi Sankyo, Foundation Medicine, Sermonix Contracted Research: Eli Lilly, AbbVie, Sermonix, Bristol Meyers Squibb, Novartis |
| Ugur Sener | Author | Nothing to disclose |
| Helen A. Shih | Author | Nothing to disclose |
| David B. Schultz | Author | Nothing to disclose |
| Scott G. Soltys | Author | Contracted Research: Novocure, Inc. Speaker’s Bureau: Zap Surgical, Inc. |
| Paul Sperduto | Author | Nothing to disclose |
| Samuel A. Sprowls | Author | Nothing to disclose |
| Ethan S. Srinivasan | Author | Nothing to disclose |
| Adriane Steindl | Author | Nothing to disclose |
| Hussein A. Tawbi | Author | Consulting Fee (e.g., Advisory Board): BMS, Merck, Genentech, Novartis, Eisai, Iovance, Karyopharm, Boxer Capital Contracted Research: BMS, Merck, Genentech, Novartis, GSK, EMD Serono |
| Manuel Valiente | Author | Nothing to disclose |
| Amanda E. D. Van Swearingen | Author | Nothing to disclose |
| Heather A. Wakelee | Author | Consulting Fee (e.g., Advisory Board): AstraZeneca, Xcovery, Janssen, Daiichi Sankyo, Mirati, Blueprint, Helsinn Contracted Research: ACEA Biosciences, Arrys Therapeutics, AstraZeneca/Medimmune, BMS, Celgene, Clovis Oncology, Exelixis, Genentech/Roche, Gilead, Merck, Novartis, Pharmacyclics, Seattle Genetics, Xcovery, Eli Lilly, Pfizer Honoraria: Novartis, AstraZeneca |
| Jianbo Wang | Author | Nothing to disclose |
| Jeffrey S. Wefel | Author | Consulting Fee (e.g., Advisory Board): Angiochem, Bayer, GT Medical Technology, Juno, Novocure, Roche, Vanquish Oncology |
| Frank Winkler | Author | Consulting Fee (e.g., Advisory Board): D&C Europa Ltd. Contracted Research: Boehringer, GSK, Roche, Genentech, Divide & Conquer |
| Helena Yu | Author | Consulting Fee (e.g., Advisory Board): Daiichi, AstraZeneca, Blueprint Medicine, Janssen Contracted Research: Funding to my institution from Daiichi, AstraZeneca, Cullinan, Pfizer, Novartis |
| Gelareh Zadeh | Author | Nothing to disclose |
| Jeffrey A. Zuccato | Author | Nothing to disclose |
| The editors reported the following financial relationships or relationships to products or devices they have with ineligible companies related to the content of this CME activity: | ||
| Name of Editor | Role | Reported Financial Relationship |
| Carey K. Anders | Editor | Consulting Fee (e.g., Advisory Board): Genentech, Eisai, IPSEN, Seattle Genetics, Astra Zeneca, Novartis, Immunomedics, Elucida, Athenex Contracted Research: PUMA, Lilly, Merck, Seattle Genetics, Nektar, Tesaro, G1-Therapeutics, ZION, Novartis, Pfizer |
| Priscilla K. Brastianos | Editor | Consulting Fee (e.g., Advisory Board): Pfizer, ElevateBio, Dantari, SK Life Sciences, Sintetica, Voyager Therapeutics Contracted Research: Merck, Eli Lilly, BMS, Mirati Honoraria: Pfizer |
| David B. Schultz | Editor | Nothing to disclose |
| Jeffrey A. Zuccato | Editor | Nothing to disclose |
| The Reviewers reported the following financial relationships or relationships to products or devices they have with ineligible companies related to the content of this CME activity: | ||
| Name of Reviewer | Role | Reported Financial Relationship |
| Mohammed Ali Alvi | Reviewer | Nothing to disclose |
| Hidefumi Aoyama | Reviewer | Nothing to disclose |
| Stephen Bagley | Reviewer | Consulting Fee (e.g., Advisory Board): Novocure, Sumitomo Dainippon Contracted Research: Incyte, Eli Lilly, GlaxoSmithKline, Novocure |
| Priscilla K. Brastianos | Reviewer | Consulting Fee (e.g., Advisory Board): Pfizer, ElevateBio, Dantari, SK Life Sciences, Sintetica, Voyager Therapeutics Contracted Research: Merck, Eli Lilly, BMS, Mirati Honoraria: Pfizer |
| Samuel Chao | Reviewer | Contracted Research: Blue Earth Diagnostics Honoraria: Varian Medical System |
| Erin M. Dunbar | Reviewer | Nothing to disclose |
| Gaetano Finocchiaro | Reviewer | Nothing to disclose |
| Isabella Glitza Olivia | Reviewer | Consulting Fee (e.g., Advisory Board): BMS, Array, Novartis Contracted Research: BMS, Merck, Pfizer |
| Jerome Graber | Reviewer | Nothing to disclose |
| Jason Huse | Reviewer | Nothing to disclose |
| Randy Jensen | Reviewer | Consulting Fee (e.g., Advisory Board): Medtronic |
| Raja B. Khan | Reviewer | Nothing to disclose |
| Albert E. Kim | Reviewer | Nothing to disclose |
| Manabu Kinoshita | Reviewer | Nothing to disclose |
| Rupesh Kotecha | Reviewer | Consulting Fee (e.g., Advisory Board): Viewray Inc., Novocure Inc. Contracted Research: Medtronic Inc, Blue Earth Diagnostics, Novocure Inc., GT Medical Technologies, AstraZeneca, Exelixis, Viewray Inc Honoraria: Accuray Inc., Elekta AB, Novocure Inc., Viewray Inc. Speakers’ Bureau: Novocure Inc |
| Andrew B. Lassman | Reviewer | Consulting Fee (e.g., Advisory Board): Abbott, AbbVie, Forma, Bioclinica (as an expert, blinded, independent reviewer of deidentified clinical data for a BMS-sponsored trial), GSK, Karyopharm, Bayer, PER/MLH Holdings, Novocure, Orbus, QED, Sapience Contracted Research: Genentech/Roche, Millenium, Celldex, Pfizer, Aeterna Zenaris, Novartis, QED, Karyopharm, AbbVie, Kadmon, BI Vaccines, Beigene, Oncoceutics, Bayer, Agios, Orbus, |
| Justin D. Lathia | Reviewer | Nothing to disclose |
| Eudocia Lee | Reviewer | Nothing to disclose |
| Nancy U. Lin | Reviewer | Consulting Fee (e.g., Advisory Board): Puma, Seattle Genetics, Daiichi Sankyo, AstraZeneca, Denali Therapeutics, Prelude Therapeutics, Pfizer Contracted Research: (all funding to institution) -- Genentech, Merck, Seattle Genetics, Pfizer, Novartis, AstraZeneca |
| Mihaela Lorger | Reviewer | Nothing to disclose |
| Ashlee Loughan | Reviewer | Nothing to disclose |
| Edjah Nduom | Reviewer | Contracted Research: Bristol-Myers Squibb. Receiving Drug-only support for clinical trial |
| David Peereboom | Reviewer | Consulting Fee (e.g., Advisory Board): Orbus Therapeutics, Inc., Sumitomo Dainippon Pharma Oncology, Inc. Contracted Research: Stemline Therapeutics, Pfizer, Novartis, NeOnc Technologies, Bristol-Myers Squibb, Genentech/Roche, Mylan Pharmaceuticals, Orbus Therapeutics, Pharmacyclics LLC, Incyte, Bayer, Mimivax |
| Maryam Rahman | Reviewer | Nothing to disclose |
| Analiz Rodriguez | Reviewer | Nothing to disclose |
| Takashi Sasayama | Reviewer | Nothing to disclose |
| David Schiff | Reviewer | Consulting Fee (e.g., Advisory Board): Glaxo Smith Kline (advisory board), Orbus and Denovo (DSMC) |
| Patricia Steeg | Reviewer | Nothing to disclose |
| Roy Strowd | Reviewer | Consulting Fee (e.g., Advisory Board): Monteris Medical, Novocure Contracted Research: Jazz Pharmaceuticals |
| Jennie Taylor | Reviewer | Contracted Research: Agios, BMS, Navio, AbbVie |
| Mehdi Touat | Reviewer | Consulting Fee (e.g., Advisory Board): Agios Pharmaceuticals Contracted Research: Sanofi |
| Seiichi Yoshida | Reviewer | Nothing to disclose |
| Gelareh Zadeh | Reviewer | Nothing to disclose |
| The planners and managers reported the following financial relationships or relationships to products or devices they have with ineligible companies related to the content of this CME activity: | ||
| Name of Planner or Manager | Role | Reported Financial Relationship |
| Lindsay Borvansky | Clinical Content Reviewer | Nothing to disclose |
| Andrea Funk | Planner/Manager | Nothing to disclose |
| Liddy Knight | Planner/Manager | Nothing to disclose |
| Ashley Cann | Planner/Manager | Nothing to disclose |
| Kim Rodriguez | Planner/Manager | Nothing to disclose |
| Angie Ames | Planner/Manager | Nothing to disclose |
| MeLesa Ritterhouse | Planner/Manager | Nothing to disclose |
| Charles Haynes | Planner/Manager | Nothing to disclose |
| Gelareh Zadeh | Planner/Manager | Nothing to disclose |
| Carey K. Anders | Planner/Manager | Consulting Fee (e.g., Advisory Board): Genentech, Eisai, IPSEN, Seattle Genetics, Astra Zeneca, Novartis, Immunomedics, Elucida, Athenex Contracted Research: PUMA, Lilly, Merck, Seattle Genetics, Nektar, Tesaro, G1-Therapeutics, ZION, Novartis, Pfizer |
| Phil Bishop | Planner/Manager | Nothing to disclose |
| Priscilla K. Brastianos | Planner/Manager | Consulting Fee (e.g., Advisory Board): Pfizer, ElevateBio, Dantari, SK Life Sciences, Sintetica, Voyager Therapeutics Contracted Research: Merck, Eli Lilly, BMS, Mirati Honoraria: Pfizer |
| Elizabeth Anne Martinson | Planner/Manager | Nothing to disclose |
| David B. Schultz | Planner/Manager | Nothing to disclose |
| Jeffrey A. Zuccato | Planner/Manager | Nothing to disclose |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.